13D/13G Filings - Blue Owl Capital Holdings LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
5:09 pm
Sale
2024-12-31 13G Sagimet Biosciences Inc.
SGMT
Blue Owl Capital Holdings LP 1,323,877
4.320%
-350,000decrease
(-20.91%)
Filing
History
2025-02-14
5:09 pm
Purchase
2024-12-31 13G Context Therapeutics Inc.
CNTX
Blue Owl Capital Holdings LP 6,357,928
8.480%
946,638increase
(+17.49%)
Filing
History
2025-02-14
5:09 pm
Sale
2024-12-31 13G AEON Biopharma, Inc.
AEON
Blue Owl Capital Holdings LP 42,352
3.810%
-4,053decrease
(-8.73%)
Filing
History
2025-02-14
5:09 pm
Sale
2024-12-31 13G Tourmaline Bio, Inc.
TRML
Blue Owl Capital Holdings LP 1,079,321
4.200%
-451,080decrease
(-29.47%)
Filing
History
2025-02-14
5:09 pm
Purchase
2024-12-31 13G Marker Therapeutics, Inc.
MRKR
Blue Owl Capital Holdings LP 554,250
5.180%
554,250increase
(New Position)
Filing
History
2025-02-14
5:09 pm
Sale
2024-12-31 13G Generation Asia I Acquisition Limited
GAQ
Blue Owl Capital Holdings LP 0
0.000%
-573,000decrease
(Position Closed)
Filing
History
2025-02-14
5:09 pm
Purchase
2024-12-31 13G FS Credit Opportunities Corp.
FSCO
Blue Owl Capital Holdings LP 50,000
16.670%
50,000increase
(New Position)
Filing
History
2025-02-14
5:09 pm
Purchase
2024-12-31 13G LUMENT FIN TR INC RED
LFTPRA
Blue Owl Capital Holdings LP 200,000
8.330%
200,000increase
(New Position)
Filing
History
2025-02-14
5:09 pm
Purchase
2024-12-31 13G ARBOR RLTY TR INC
ABRPRE
Blue Owl Capital Holdings LP 360,000
6.260%
360,000increase
(New Position)
Filing
History
2024-11-14
5:05 pm
Sale
2024-09-30 13G Syros Pharmaceuticals, Inc.
SYRS
Blue Owl Capital Holdings LP 515,855
1.920%
-977,397decrease
(-65.45%)
Filing
History
2024-11-14
5:05 pm
Unchanged
2024-09-30 13G Pliant Therapeutics, Inc.
PLRX
Blue Owl Capital Holdings LP 3,004,199
4.940%
0
(Unchanged)
Filing
History
2024-11-14
5:05 pm
Sale
2024-09-30 13G Cullinan Oncology, Inc.
CGEM
Blue Owl Capital Holdings LP 2,010,972
3.450%
-1,408,870decrease
(-41.20%)
Filing
History
2024-11-14
5:05 pm
Sale
2024-09-30 13G Orchard Therapeutics plc
ORTX
Blue Owl Capital Holdings LP 0
0.000%
-15,596,600decrease
(Position Closed)
Filing
History
2024-11-14
5:05 pm
Purchase
2024-09-30 13G enGene Holdings Inc. Common Stock
ENGN
Blue Owl Capital Holdings LP 3,095,069
7.000%
1,860,309increase
(+150.66%)
Filing
History
2024-11-14
5:05 pm
Purchase
2024-09-30 13G Tourmaline Bio, Inc.
TRML
Blue Owl Capital Holdings LP 1,530,401
6.000%
198,099increase
(+14.87%)
Filing
History
2024-11-14
5:05 pm
Purchase
2024-09-30 13G Larimar Therapeutics, Inc.
LRMR
Blue Owl Capital Holdings LP 4,166,829
6.530%
752,361increase
(+22.03%)
Filing
History
2024-11-14
5:05 pm
Purchase
2024-09-30 13G Repare Therapeutics Inc.
RPTX
Blue Owl Capital Holdings LP 3,372,499
7.930%
250,000increase
(+8.01%)
Filing
History
2024-11-14
5:05 pm
Purchase
2024-09-30 13G Sagimet Biosciences Inc.
SGMT
Blue Owl Capital Holdings LP 1,673,877
5.460%
1,673,877increase
(New Position)
Filing
History
2024-11-14
5:05 pm
Purchase
2024-09-30 13G Context Therapeutics Inc.
CNTX
Blue Owl Capital Holdings LP 4,091,118
8.480%
4,091,118increase
(New Position)
Filing
History
2024-11-14
5:05 pm
Purchase
2024-09-30 13G Nuveen Churchill Direct Lending Corp.
NCDL
Blue Owl Capital Holdings LP 4,039,552
7.410%
4,039,552increase
(New Position)
Filing
History
Goto 0, 1, Next